Revenue by Product Line for the three months period ended March 31 (YoY) Product Line/ Business Group Consolidated financial statements Change Increase/(Decrease) For Three Months Period Ended 31 March 2018
million in the second quarter of 2018. A summary of the Company’s operating performance in the second quarter of 2019 and 2018 is shown in the following table: 2Q19 1Q19 % Change 2Q18 % Change [Amount in
revenues EMS business The Company had revenue from EMS business for the second quarter of 2019 amounting to Baht 387 million. There was no significant change compared to the same period of the previous year
Bt559.7million in the third quarter of 2018. A summary of the Company’s operating performance in the third quarter of 2019 and 2018 is shown in the following table: 3Q19 2Q19 1Q19 % Change 3Q18 % Change [Amount in
Topic Balance by Quarter Change Q1–21 Q4–20 Q1–20 Q1–21 VS Q4–20 Q1–21 VS Q1–20 (Million Baht: MB) (MB) % (MB) % Total revenue 1,824.2 2,070.7 1,231.6 (246.5) (11.9) 592.6 48.1 Total operating expenses
Topic Balance by Quarter Change Q1–21 Q4–20 Q1–20 Q1–21 VS Q4–20 Q1–21 VS Q1–20 (Million Baht: MB) (MB) % (MB) % Total revenue 1,824.2 2,070.7 1,231.6 (246.5) (11.9) 592.6 48.1 Total operating expenses
empower the Executive Committee or the Managing Director to amend or change the date of determination of shareholders who shall be entitled to attend the Extraordinary General Meeting of Shareholders No1
under Section 225 of the Securities and Exchange Act B.E. 2535 (as amended), and to empower the Executive Committee or the Managing Director to amend or change the date of determination of shareholders
under Section 225 of the Securities and Exchange Act B.E. 2535 (as amended), and to empower the Executive Committee or the Managing Director to amend or change the date of determination of shareholders
, change in regulation for retirement provisioning). As a result after a very successful 2018 with over 24% topline and 30% EBITDA growth, this year has witnessed a 13% revenue and 28% consolidate EBITDA